WHO Raises Warning Over Severe Scarcity of Weight-Loss Medications
Under a tenth of individuals eligible to benefit from weight-loss injections such as Wegovy are able to get them, caution the WHO as it releases its first advice on the drugs.
Considering in excess of 1,000,000,000 people worldwide currently classified as obese, it is advocating for broader and more equitable availability to these injectable treatments.
According to projections, more than two billion could be living with obesity by 2030 without intervention.
"Our latest guidance acknowledges that excess weight is a long-term condition that can be managed with holistic and ongoing treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are significant obstacles to universal availability to the injections that can aid individuals in losing significant body mass, explains the agency.
Weight-Loss Drug Supply Crisis
Even in the current best projected outlook, the manufacturing of such drugs might only reach approximately 100 million people – less than 10% of eligible patients, per the health organization.
The recommendation calls on governments and firms to expand availability, via strategies like voluntary licensing.
The intellectual property rights on the active ingredient – the core component of the drug Wegovy – is scheduled to end in several countries in 2026.
How Weight-Loss Injections Operate
These medications replicate a natural hormone to slow digestion, reduce hunger and boost satiety so individuals consume fewer calories.
People commonly begin shedding pounds within a few weeks of starting on the regular doses.
Evidence suggests patients may regain a significant portion a year later of halting the drug, as their normal hunger come back.
Being overweight or obese increases your chance for developing diseases, such as type 2 diabetes, cardiovascular issues, brain attack, and specific cancers.
Excess weight concerns individuals in every country and was responsible for millions of fatalities worldwide in 2024, as per the health agency.
